For the last seven years, the LSX World Congress has bought together biotech, medtech and healthtech executives to connect with the capital, intelligence, innovation, and partners they need to grow their businesses. Back in-person for 2022, the 8th Congress takes place 10-11 May at 133 Houndsditch in London.
The event gathers the founders and CEOs of innovative start-ups through to publicly healthcare giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.
The biotech, healthtech and medtech industry’s c-suite will be joined by the sector’s most active investors, pharma and health technology BD&L teams, R&D leaders, KOLs and top tier service companies who are driving the sector forward.
In an industry as dynamic as this, the Congress brings together the people who are developing technologies, solutions and new business models to tackle the biggest healthcare challenges in the industry today, and helps answer the question; what’s next and how do we get there?
With a relentless focus on quality peer-to-peer discussion, high-level networking and partnering, intimate conference formats and a vetted, high-calibre audience, the Congress in a must attend.
See full details at www.lsxleaders.com/world
DDW exclusive discount
There is a 15% discount for the DDW community. Use the code ‘DDW15’ at check out. See full details at www.lsxleaders.com/world.